CANTABio Pharmaceuticals CTBO could emerge as the big winner in the race to end Alzheimer’s and Parkinson’s with its focus on the novel DJ-1 Protein.
The article's focus is selling CTBO stock.
There is, however, hope.
As you will soon discover, medical science is finally beginning to make those crucial breakthroughs in the understanding and potential treatment of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and ALS — among others.
A cure for these and other brain disorders may be just around the corner!